Biomarkers of diabetes

A molecular biomarker is a gene, molecule, or natural trait that helps recognize disease. In diabetes, HbA1c is considered a biomarker to identify risk factors for retinopathy, vascular disease and nephropathy. These provide preventative measures during the subclinical phase. The proper use of the biomarker in the growth of anti-diabetic drugs can help in a quick and better understanding of the pathological process of diabetes.


    Related Conference of Biomarkers of diabetes

    November 13-14, 2024

    33rd International Diabetes and Healthcare Conference

    Paris, France
    November 18-19, 2024

    3rd International Summit on Hormonal Disorders

    Madrid, Spain
    November 22-23, 2024

    20th World Congress on Endocrinology & Diabetes

    Amsterdam, Netherlands
    November 27-28, 2024

    7th Annual Meeting on Diabetes and Endocrinology

    Paris, France
    November 27-28, 2024

    14th World Congress on Endocrinology and Diabetes

    Paris, France
    February 24-25, 2025

    34th European Diabetes Congress

    London, UK
    March 17-18, 2025

    5th European Endocrinology and Diabetes Congress

    Paris, France
    April 10-11, 2025

    5th World Congress on Endocrine and Diabetes

    Dubai, UAE
    May 19-20, 2025

    6th World Summit on Diabetes

    Rome, Italy
    June 04-05, 2025

    4th World Congress on Diabetes and Pediatric Endocrinology

    Edinburgh, Scotland

    Biomarkers of diabetes Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in